Diazeppam - Sanguino
SanguinoEU
SanguinoEU
Updated Aug 05, 2026, 03:00 UTC · 3 days ago · data from the Blizzard Battle.net API · data may be delayed
Holy Paladin · Build 1 import string
Holy Paladin · Build 2 import string
Holy Paladin · Build 3 import string
Holy Paladin · Build 4 import string
Holy Paladin · Build 5 import string
Protection Paladin · Build 1 import string
Protection Paladin · Build 2 import string
Retribution Paladin · Build 1 import string
Retribution Paladin · Build 2 import string
Retribution Paladin · Build 3 import string
Retribution Paladin · Build 4 import string
Gear: 246 item level · 0/8 enchants · 1/3 gems — see full loadout, enchants & gems.
| Bracket | Rating | Rank | W–L | Games | Win% |
|---|---|---|---|---|---|
| #605 | 430–408 | 838 | 51% | ||
| 2v2 Arena | #4049 | 94–67 | 161 | 58% | |
| #1869 | 5–3 | 8 | 62% |

Secondary stats as the character was last geared & logged out.
| Battleground | Played | W–L | Win% |
|---|---|---|---|
| Warsong Gulch | 25 | 11–14 | 44% |
| Twin Peaks | 23 | 14–9 | 61% |
| Deepwind Gorge | 20 | 12–8 | 60% |
| Arathi Basin | 16 | 5–11 | 31% |
| Temple of Kotmogu | 15 | 11–4 | 73% |
| Battleground | Played | W–L | Win% |
|---|---|---|---|
| Deephaul Ravine | 15 | 7–8 | 47% |
| Silvershard Mines | 13 | 3–10 | 23% |
| Seething Shore | 13 | 9–4 | 69% |
| Eye of the Storm | 10 | 3–7 | 30% |
| The Battle for Gilneas | 10 | 8–2 | 80% |
| Rated Eye of the Storm | 10 | 6–4 | 60% |
| Isle of Conquest | 1 | 0–1 | 0% |
| Korrak's Revenge | 1 | 0–1 | 0% |
| Dungeon | Key | Time | Date |
|---|---|---|---|
| Maisara Caverns | +12 | 36:11 ✕ | — |
| Nexus-Point Xenas | +11 | 26:08 ★ | — |
| Maisara Caverns | +10 | 23:21 ★ | — |
| Skyreach | +10 | 30:02 ✕ | — |
| Skyreach | +10 | 18:01 ★ | — |
| Algeth'ar Academy | +10 | 25:51 ★ | — |
| Magisters' Terrace | +10 | 21:15 ★ | — |
| Seat of the Triumvirate | +8 | 24:58 ★ | — |
| Windrunner Spire | +7 | 33:40 ✕ | — |
| Pit of Saron | +6 | 21:41 ★ | — |
| Windrunner Spire | +2 | 17:49 ★ | — |
11,985 achievement points · honor level 322 · ranked in 3 brackets
Currently wearing the Seeker
No titles match that search.
No reputations match that search.
See every mount Diazeppam has collected - loaded live from the armory. Click below to pull the current collection straight from Blizzard.
See every battle pet Diazeppam has collected - loaded live from the armory. Click below to pull the current collection straight from Blizzard.
Diazeppam peaks at 2439 rating (Elite) in Solo Shuffle - Holy Paladin, and is ranked across 3 rated brackets this season on Sanguino (EU).
Yes — Diazeppam carries a Mythic+ rating of 2434 alongside their rated PvP this season.
Diazeppam's highest-rated Solo Shuffle spec is Holy Paladin at 2439 rating (Elite).
Diazeppam wins 51% of their Solo Shuffle - Holy Paladin games this season (430–408).
Diazeppam is a Holy Paladin on Sanguino (EU) who ranks among the bracket's elite this season, ranked across 3 rated brackets. Their best result is 2439 rating (Elite) in Solo Shuffle - Holy Paladin, placing them in the top 12% of the bracket.
Their active specialisation is Holy Paladin, carrying gear across 16 slots, including 15 epic pieces and 1 gems socketed and a modest item level of just 246 for their bracket. Outside combat, Diazeppam keeps up Skinning, Herbalism and Fishing. Their current talent build is available to copy below, or open it in our interactive talent calculator.
Diazeppam has played 1,007 rated games this season. With a 1043-point gap between their top and bottom brackets, their attention is clearly weighted toward one format. Top of the sheet right now: #605 in Solo Shuffle - Holy Paladin (2439), #4049 in 2v2 Arena (2240), #1869 in Battleground Blitz - Holy Paladin (1396).
Their record reaches past the arena — Diazeppam carries a Mythic+ rating of 2434 and 63 earned titles. Full gear, talents, battleground win rates and PvE progression are broken down below; you can also see how they place on our Mythic+ leaderboards and PvP ladders.
View Diazeppam on the official WoW Armory →
Profile data as of Jul 26, 2026.